Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
BMC Neuroscience
|
December 19, 2008
Requirements for a lead compound to become a clinical candidate
Franz F Hefti
Aging Cell
|
January 31, 2006
Regulatory issues in aging pharmacology
Franz F Hefti, Roxanne Bales
Trends in Pharmacological Sciences
|
December 27, 2005
Novel class of pain drugs based on antagonism of NGF
Franz F Hefti, Arnon Rosenthal, Patricia A Walicke, et al.
PET Clinics
|
May 10, 2016
(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons
Franz F Hefti, Hank F Kung, Michael R Kilbourn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 11, 2012
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit
Mary D Naylor, Jason H Karlawish, Steven E Arnold, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
BMC Neuroscience
|
December 19, 2008
Requirements for a lead compound to become a clinical candidate
Franz F Hefti
Aging Cell
|
January 31, 2006
Regulatory issues in aging pharmacology
Franz F Hefti, Roxanne Bales
Trends in Pharmacological Sciences
|
December 27, 2005
Novel class of pain drugs based on antagonism of NGF
Franz F Hefti, Arnon Rosenthal, Patricia A Walicke, et al.
PET Clinics
|
May 10, 2016
(18)F-AV-133: A Selective VMAT2-binding Radiopharmaceutical for PET Imaging of Dopaminergic Neurons
Franz F Hefti, Hank F Kung, Michael R Kilbourn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
September 11, 2012
Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit
Mary D Naylor, Jason H Karlawish, Steven E Arnold, et al.
Page
of 1